+
-ATPase as an energy transducing ion pump has been studied extensively since its discovery in 1957. Although early findings suggested a role for Na + /K + -ATPase in regulation of cell growth and expression of various genes, only in recent years the mechanisms through which this plasma membrane enzyme communicates with the nucleus have been studied. This research, carried out mostly on cardiac myocytes, shows that in addition to pumping ions, Na + /K + -ATPase interacts with neighboring membrane proteins and organized cytosolic cascades of signaling proteins to send messages to the intracellular organelles. The signaling pathways that are rapidly elicited by the interaction of ouabain with Na + /K + -ATPase, and are independent of changes in intracellular Na + and K + concentrations, include activation of Src kinase, transactivation of the epidermal growth factor receptor by Src, activation of Ras and p42/44 mitogen-activated protein kinases, and increased generation of reactive oxygen species by mitochondria. In cardiac myocytes, the resulting downstream events include the induction of some early response proto-oncogenes, activation of the transcription factors, activator protein-1 and nuclear factor kappa-B, regulation of a number of cardiac growth-related genes, and stimulation of protein synthesis and myocyte hypertrophy. For these downstream events, the induced reactive oxygen species and rise in intracellular Ca 2+ are essential second messengers. In cells other than cardiac myocytes, the proximal pathways linked to Na 
I N T R O D U C T I O N
In 1957, J. C. Skou reported the discovery of the Na + /K + -ATPase and proposed its role in the active extrusion of Na + from the nerve cell [1] . Soon thereafter, sufficient evidence was available to establish that this enzyme is indeed the molecular machine that uses the energy of hydrolysis of ATP for the coupled active transports of Na + and K + (the sodium pump) across the plasma membrane of nearly all animal cells [2] . In the ensuing decades, extensive work has been carried out on the structure-function of Na + /K + -ATPase as an energy transducing ion pump. This research has been summarized in numerous previous reviews and monographs, and is updated in one of the accompanying reviews [3] . Here, we address a newer aspect of the biology of Na + /K + -ATPase; i.e. the mechanisms and the pathways by which the enzyme acts as a signal transducer to relay messages, through protein-protein interactions, from the plasma membrane to the nucleus.
It has been known for a long time that Na + /K + -ATPase communicates with the nucleus to regulate genes and cell growth. What is new is the realization that this communication occurs through the properties of Na + /K + -ATPase that are distinct from its function as an ion pump.
That the enzyme is capable of controlling expression of its own genes was suggested in 1974 [4] . Pressley [5] has reviewed the studies of various groups showing that chronic inhibition of the sodium pump of the cultured cells, either by the pump inhibitor ouabain or by lowering of [K + ] o , leads to an increased abundance of functional Na + /K + -ATPase in the plasma membrane; and that this increase is due, in part, to the transcriptional up-regulation of the enzyme subunits. In these and subsequent studies on the adaptive upregulation of the enzyme due to its inhibition, the general conclusion has been that the intracellular ionic changes resulting from pump inhibition are responsible for the noted regulation [5] [6] [7] [8] A large body of work reviewed by Kaplan [15] showed, as early as 1968 [16] , that ouabain interaction with Na + /K + -ATPase inhibits mitogen-induced differentiation and proliferation of lymphocytes. Although these effects and subsequent proliferative ouabain effects on some cells [17] were also generally ascribed to altered intracellular ion concentrations, it is of interest to note that later observations clearly suggested that some growth-related effects of ouabain on lymphocytes may indeed be dissociated from ouabain-induced changes in intracellular ions [18] [19] [20] .
In mid-1990s, our laboratories became interested in the possible role of Na + /K + -ATPase in the nonproliferative growth (hypertrophy) of the heart. This was partly due to the established, but relatively ignored, effects of ouabain on lymphocyte growth mentioned above; and partly due to the growing realization that the well known hypertrophy of the failing heart may not be only an adaptive and beneficial response of the diseased heart as stated in textbooks, but rather a part of the continuum of the derangements leading to advanced heart failure. Because of the latter, at the time there was extensive ongoing research on the mechanisms by which a variety of hormones, neurotransmitters, cytokines, mitogens, and mechanical stimuli affect cardiac myocyte hypertrophy [21] . Interestingly, in this highly active field, there seemed to be no focus on how the cardiac Na + /K + -ATPase and its clinically used specific inhibitors, the digitalis drugs, may be involved in cardiac hypertrophy. Considering that digitalis drugs were, and remain to be, a mainstay of the treatment of the failing heart, it seemed to us that exploration of the effects of these drugs on cardiac hypertrophy deserved more attention. Using the cultured cardiac myocytes as a model, our studies of the past few years [22] [23] [24] [25] [26] have clearly indicated that the same nontoxic concentrations of ouabain that cause partial inhibition of Na + /K + -ATPase and an increase in cardiac contractility, also stimulate myocyte growth and protein synthesis, induce a number of early response proto-oncogenes, activate transcription factors activator protein 1 (AP-1) and NF-jB, and induce or repress the transcription of several late-response cardiac marker genes that are also regulated by other cardiac hypertrophic stimuli. These findings clearly establish that Na future. In the highly active area of research on cardiac hypertrophy, there has been some tendency to overemphasize the importance of this entity or that pathway [27] . In view of the multiplicity of the stimuli and receptors that have been shown to regulate cardiac hypertrophy, and because of the evident overlap and superficial similarities of the signal pathways linked to such stimuli/receptors, it would be naively optimistic to think that focus on one entity and neglect of others may resolve the problem of cardiac hypertrophy/failure. We suggest that it is more important to recognize that multiple signals, receptors, pathways, and second messenger are involved in the control of myocyte growth, and that it is essential to delineate the pathways activated by each signal/receptor, and the nature of crosstalk among these, before the consequences of the pathological derangement of the interacting networks linked to different receptors can be understood. In this context, the mapping of the signaling pathways coupled to Na + /K + -ATPase, and the clarification of the mechanisms involved in pump interaction with neighboring receptors, has been the focus of our recent research.
S E C O N D M E S S E N G E R S , S I G N A L I N G I N T E R M E D I A T E S , A N D P A T H W A Y S L I N K E D T O C A R D I A C N A + / K + -A T P A S E T H R O U G H P R O T E I N -P R O T E I N I N T E R A C T I O N S
To date, most of the work on signal transduction by Na + /K + -ATPase has been carried out on cardiac myocytes. It is convenient to present the information on myocytes first, and then discuss the emerging data on other cell types. 
Pathways that are independent of changes in intracellular ions
Because the cardiac myocyte plasma membrane contains a highly active Na + /Ca 2+ -exchanger, the most significant intracellular ionic change that results from the partial, but nontoxic, inhibition of cardiac Na [29, 30] . The present state of knowledge about these proximal pathways may be summarized as follows. The earliest specific ouabain-induced event that has been identified is the activation of Src kinase which leads to tyrosine phosphorylation of a number of cellular proteins, including the epidermal growth factor (EGF) receptor [29] . Although it is possible that other receptor or nonreceptor tyrosine kinases may also be activated by ouabain, the transactivation of the EGF receptor by Src is sufficient to account for the recruitments of Shc (SH-2 domain-containing protein), Grb2, Sos (a mammalian homologue of Son-of-sevenless), and Ras to the plasma membrane [25, 29] . Whether Src interacts with Na + /K + -ATPase directly or indirectly is not known [29] ; this is the subject of ongoing studies. Upon ouabain-induced activation of the G-protein Ras, a pathway is initiated (the details of which are not known), which clearly extends from the plasma membrane to the mitochondria where it leads to increase in generation of ROS [26, 30] . This increase in ROS is an essential second messenger for many, but not all, of the downstream events that are linked to Na , most likely due to PKC activation of Raf whose recruitment to the membrane has been induced by Ras. Unsurprisingly, activation of PKC seems to be due to activation of phospholipase C (PLC)-c that is also recruited to the ouabain-activated Src/ ] i , both of which are essential for the full expression of the hypertrophic and gene regulatory actions of ouabain; and each is generated in parallel with the other [30] . The inescapable conclusion is that there are two pools of Na + /K + -ATPase within the plasma membrane with two distinct functions: one being the classical pool of the enzyme as an energy transducing ion pump whose partial inhibition by ouabain initiates the increase in [Ca 2+ ] i , and the other the signal transducing pool of the enzyme which, through protein-protein interactions, leads to the activation of a host of signaling intermediates and a rise in intracellular ROS. In cardiac myocytes, the functions of these two pools are tightly coupled through feed-back cycles to regulate cardiac contractility and growth.
S I G N A L T R A N S D U C I N G R O L E O F N A + / K + -A T P A S E I N C E L L S O T H E R T H A N C A R D I A C M Y O C Y T E S
Relevant information on cell types other than cardiac myocytes is more limited, but rapidly increasing. It is already clear that linkage to signaling intermediates and pathways through protein-protein interactions is a common property of Na + /K + -ATPase in most, if not all, cells. Using partially inhibitory concentrations of ouabain, activation of parts or all of the pathways that begin with protein tyrosine phosphorylation and lead to ROS generation and MAPK activation (Fig. 1) has been shown in A7r5 cells and HeLa cells [29, 30] . The findings on HeLa cells are of particular interest for two reasons. First, activation of signal pathways in these cells of human origin are obtained at ouabain concentrations that are about two to three orders of magnitude lower than those that elicit similar effects in rodent cells [29] [30] [31] [32] . This is in keeping with the relative ouabain sensitivities of the predominant Na . We have already mentioned the older work [18] [19] [20] showing inhibitory ouabain effects on lymphocyte proliferation at ouabain concentrations shown to be without effect on intracellular ions. Although these studies were carried out before the development of many of the current concepts of signal transducing pathways, it is appropriate to note that with remarkable insight these ouabain effects were ascribed to protein-protein interactions between Na + /K + -ATPase and other plasma membrane proteins [19] .
Changes 
T H E P H Y S I O L O G I C A L S T I M U L I F O R S I G N A L T R A N S D U C T I O N B Y N A + / K + -A T P A S E
The signal transducing receptors of the plasma membrane respond to specific extracellular stimuli such as hormones 
C O N C L U S I O N S A N D F U T U R E P R O S P E C T S
The work of the past few years, built on the foundation of a number of excellent but somewhat ignored studies of the past three decades, has clearly shown that in addition to its established role as an ion pump, Na + /K + -ATPase also functions as a signal transducer to relay messages from the plasma membrane to the intracellular organelles through stimulus-induced protein-protein interactions involving the Na + /K + -ATPase, the neighboring plasma membrane proteins, and the organized cytoplasmic protein assemblies. An important point that is already evident from the work carried out to date is that while Na 
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